ClinicalTrials.Veeva

Menu

Evaluation of Group CBT Programme With Breast Cancer Patients

R

Royal Marsden NHS Foundation Trust

Status

Unknown

Conditions

Breast Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT00426335
CCR2839

Details and patient eligibility

About

The purpose of this study is to examine whether a group CBT intervention is effective in reducing psychological distress in women with primary breast cancer.

Full description

The diagnosis and treatment of cancer is associated with high levels of psychological distress, which can be long-term in duration. The end of adjuvant therapy can be a time which patients find anxiety provoking; as concerns of recurrence and how to return to life after treatment often arise at this juncture.

Cognitive behaviour therapy has demonstrated efficacy in reducing anxiety and depression in people with cancer on a 1:1 basis. The CBT model has been shown to be significantly more beneficial than supportive counselling. Therapy delivered in groups is considered desirable because of its cost effectiveness, and its potential to confer additional benefits in terms of peer support, reduced isolation and modelling of adaptive strategies by other group members.

No studies have looked at the changes in participants health beliefs and beliefs about their ability to copy (self-efficacy) with stress and tolerance of uncertainty following group CBT and the relationship with psychological distress.

The aim of this study is to evaluate a GCBT programme intervention against a waiting list control and to examine its effects on health beliefs, self-efficacy, coping, tolerance of uncertainty and psychological distress in women with early diagnosed breast cancer.

Enrollment

78 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female
  • Primary breast cancer
  • post adjuvant treatment

Exclusion criteria

  • Women with metastatic disease
  • Severe cognitive impairment (will not be able to obtain consent or participant in group intervention)
  • Inability to complete a questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Mary Burgess; Maggie Watson, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems